DETERMINING ALLOSTERIC REGULATION OF RIBONUCLEOTIDE REDUCTASE
确定核糖核苷酸还原酶的变构调节
基本信息
- 批准号:8168655
- 负责人:
- 金额:$ 0.27万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-01-01 至 2010-12-31
- 项目状态:已结题
- 来源:
- 关键词:Allosteric RegulationAntineoplastic AgentsCellsComplexComputer Retrieval of Information on Scientific Projects DatabaseDNA biosynthesisDeoxyribonucleotidesFundingGoalsGrantHumanInstitutionNucleotidesProductionProliferatingResearchResearch PersonnelResourcesRibonucleotide ReductaseSeriesSourceStructural ModelsStructureSystemUnited States National Institutes of HealthWorkYeastsresearch study
项目摘要
This subproject is one of many research subprojects utilizing the
resources provided by a Center grant funded by NIH/NCRR. The subproject and
investigator (PI) may have received primary funding from another NIH source,
and thus could be represented in other CRISP entries. The institution listed is
for the Center, which is not necessarily the institution for the investigator.
Ribonucleotide reductase (RNR) catalyzes the rate-limiting step in production of the pool of deoxyribonucleotides necessary for DNA replication. Crucial for rapidly proliferating cells, RNR is a successful target for anti-HSV and anticancer drugs. Though there are crystal structures of the Rnr2p+Rnr4p heterodimer and the recently solved Rnr1p structure from our lab, the structural details of the assembly of the yeast RNR complex and the oligomerization state of Rn1p is not known. The overall goal of our experiments is to characterize interactions between Rnr1p and Rnr2p+Rnr4p complex, and to determine how Rnr1p undergo nucleotide dependent oligomerization. We will also extend this work to study the dNTP dependent oligomerization of the human RNR system. During this proposal we will perform a series of small-angle x-ray scattering experiments to provide a structural model for the higher-order RNR complex.
这个子项目是许多研究子项目中的一个
由NIH/NCRR资助的中心赠款提供的资源。子项目和
研究者(PI)可能从另一个NIH来源获得了主要资金,
因此可以在其他CRISP条目中表示。所列机构为
研究中心,而研究中心不一定是研究者所在的机构。
核糖核苷酸还原酶(RNR)催化DNA复制所必需的脱氧核糖核苷酸池的产生中的限速步骤。RNR对于快速增殖的细胞至关重要,是抗HSV和抗癌药物的成功靶点。虽然有Rnr 2 p + Rnr 4p异二聚体的晶体结构和我们实验室最近解决的Rnr 1 p结构,但酵母RNR复合物组装的结构细节和Rn 1 p的寡聚化状态尚不清楚。我们的实验的总体目标是表征Rnr 1 p和Rnr 2 p + Rnr 4p复合物之间的相互作用,并确定Rnr 1 p如何进行核苷酸依赖性寡聚化。我们还将扩展这项工作,以研究人类RNR系统的dNTP依赖性寡聚化。在这个建议中,我们将进行一系列的小角度X射线散射实验,提供一个结构模型的高阶RNR复杂。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Chris G Dealwis其他文献
Chris G Dealwis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Chris G Dealwis', 18)}}的其他基金
Investigating the structural assembly of RNR multimers
研究 RNR 多聚体的结构组装
- 批准号:
8475488 - 财政年份:2012
- 资助金额:
$ 0.27万 - 项目类别:
Investigating the structural assembly of RNR multimers
研究 RNR 多聚体的结构组装
- 批准号:
8909392 - 财政年份:2012
- 资助金额:
$ 0.27万 - 项目类别:
Investigating the structural assembly of RNR multimers
研究 RNR 多聚体的结构组装
- 批准号:
8669995 - 财政年份:2012
- 资助金额:
$ 0.27万 - 项目类别:
Investigating the structural assembly of RNR multimers
研究 RNR 多聚体的结构组装
- 批准号:
8264407 - 财政年份:2012
- 资助金额:
$ 0.27万 - 项目类别:
CHARACTERIZATION OF NUCLEOTIDE DEPENDANT OLIOGOMERIC STATES OF RNR1P USING SAXS
使用 SAXS 表征 RNR1P 的核苷酸依赖性寡聚态
- 批准号:
8168654 - 财政年份:2010
- 资助金额:
$ 0.27万 - 项目类别:
STRUCTURAL STUDIES OF EUKARYOTIC RIBONUCLEOTIDE REDUCTASE
真核核糖核苷酸还原酶的结构研究
- 批准号:
8171985 - 财政年份:2010
- 资助金额:
$ 0.27万 - 项目类别:
STRUCTURAL STUDIES OF YEAST RIBONUCLEOTIDE REDUCTASE, AMYLOID-RECOGNIZING ANT
酵母核糖核苷酸还原酶、淀粉样蛋白识别蚂蚁的结构研究
- 批准号:
7956850 - 财政年份:2009
- 资助金额:
$ 0.27万 - 项目类别:
STRUCTURAL STUDIES OF YEAST RIBONUCLEOTIDE REDUCTASE, AMYLOID-RECOGNIZING ANT
酵母核糖核苷酸还原酶、淀粉样蛋白识别蚂蚁的结构研究
- 批准号:
7956842 - 财政年份:2009
- 资助金额:
$ 0.27万 - 项目类别:
相似海外基金
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
- 批准号:
9975367 - 财政年份:2020
- 资助金额:
$ 0.27万 - 项目类别:
Eliminate the difficulty of venous puncture in patients receiving antineoplastic agents - Development of a new strategy for the prevention of induration-
消除接受抗肿瘤药物的患者静脉穿刺的困难 - 制定预防硬结的新策略 -
- 批准号:
16K11932 - 财政年份:2016
- 资助金额:
$ 0.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Molecular mechanisms of the antineoplastic agents inhibiting DNA replication and their applications to cancer patient treatmen
抗肿瘤药物抑制DNA复制的分子机制及其在癌症患者治疗中的应用
- 批准号:
19591274 - 财政年份:2007
- 资助金额:
$ 0.27万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
PNET EXPERIMENTAL THERAPEUTICS--ANTINEOPLASTIC AGENTS AND TREATMENT DELIVERY
PNET 实验治疗——抗肿瘤药物和治疗实施
- 批准号:
6346309 - 财政年份:2000
- 资助金额:
$ 0.27万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
2885074 - 财政年份:1999
- 资助金额:
$ 0.27万 - 项目类别:
TYROSINE KINASE INHIBITORS AS ANTINEOPLASTIC AGENTS
酪氨酸激酶抑制剂作为抗肿瘤剂
- 批准号:
6174221 - 财政年份:1999
- 资助金额:
$ 0.27万 - 项目类别: